Eric Gaukel has extensive experience in nonclinical operations and drug disposition, with a career spanning over 18 years in the pharmaceutical industry. Currently serving as Senior Director of Nonclinical Operations at Roivant Sciences since February 2019, Eric has played a crucial role in establishing scientific rationales for novel in-licensing opportunities and developing strategies for pre-IND and clinical stage assets. Prior positions at Roivant Sciences included Associate Director and Director of Nonclinical Operations, where Eric focused on operationalizing support for drug candidates. Additional roles at organizations such as Discovery and Development DMPK, Avista Pharma Solutions, SCYNEXIS, and GSK contributed to a strong foundation in DMPK and ADME studies. Eric holds a Bachelor of Science degree in Genetics from the University of Wisconsin-Madison.
This person is not in any teams
This person is not in any offices